Quick Takeaways
- Christopher Peetz has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $37,908,366.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Christopher Peetz
- Location
- Foster City, CA
- Summary
- The estimated net worth of Christopher Peetz is at least $37,908,366 dollars as of 17 Mar 2026. Christopher Peetz is the CHIEF EXECUTIVE OFFICER, Director of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $37.91M.
- Signature
- /s/ Judit Ryvkin, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher Peetz and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Mirum Pharmaceuticals, Inc. ($37,908,366).
- Past-year value change for that position: -$10,720,152.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christopher Peetz
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | $37,908,366 | -$10,720,152 | -22% | 15 Mar 2026 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Director | $0 | 20 May 2024 |
Insider Transactions Reported by Christopher Peetz:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.